Showing results (1291-1300 of 8,142) with videos related to

Sort By:
Pageof 815
Haematologica|October 30, 2025
Clinical and germline risk factors for multiple treatment-related toxicities in pediatric acute lymphoblastic leukemiaMarion K Mateos, Chelsea Mayoh, Patricia Sullivan, et al.
Haematologica|November 13, 2025
Novel and emerging therapeutic strategies for clonal haematopoiesisMohsen Hosseini, Steven M Chan
Haematologica|November 13, 2025
The ABCs of donor selection: availability before compatibility?Brian C Shaffer, Miguel Angel Perales
Haematologica|December 4, 2025
The LSC17 score: a prognostic biomarker now validated for real-world clinical application in acute myeloid leukemiaMichael Sandhu, Marina Konopleva
Haematologica|October 30, 2025
Marked survival gains in patients ≤ 65 years with advanced-stage mantle cell lymphoma: a pooled analysis of six randomized phase III trials, 1996-2020Linmiao Jiang, Marco Ladetto, Olivier Hermine, et al.
Haematologica|August 18, 2025
Selection of unrelated donors for allogeneic transplantation using post-transplant cyclophosphamide in acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationJaime Sanz, Allain-Thibeault Ferhat, Alexander Kulagin, et al.
Haematologica|September 11, 2025
Impact of demographic factors on clinical outcomes of patients with acute myeloid leukemiaCassandra Duarte, Diana Abbot, Grace Bosma, et al.
Haematologica|September 11, 2025
The glutaminase activity of ASNS fuels glutamine metabolism in leukemiaWai-Kin Chan, Lin Tan, Sara A Martinez, et al.
Haematologica|August 18, 2025
Do high-volume centers really save more lives? A call for scientific rigor and transparency. Comment on: Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell TherapyDries Deeren
Haematologica|August 18, 2025
Safety and efficacy of BCMA CAR-T vs. bispecific antibodies in patients with relapsed multiple myeloma: a systematic review and meta-analysisHayley Vandenboom, Othman Akhtar, Aniko Szabo, et al.
Pageof 815